2021 was a bright year for many pharmaceutical firms, especially those able to find widespread support for COVID-19 vaccines and therapies. But it would be wrong to take a myopic view of the pandemic as a chief growth driver for leading drug developers. The most significant impact of the pandemic may be how it changed…
Pharma 50: Here’s how the world’s largest pharma companies are doing
The global pharmaceutical industry held up well during the pandemic, with 10 of the largest businesses only seeing a roughly –3% drop in revenue in 2020. Eight of the 10 even came out ahead. That’s one of the big takeaways from our sister publication Drug Discovery & Development’s inaugural Pharma 50, a compilation of data…